Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combined Obstetric and Thrombotic Complications Are Associated with Features Suggestive of an Immune-Enriched Phenotype Among Women with Thrombotic Antiphospholipid Syndrome (APS).

Diagnostics (Basel, Switzerland)·2026
Same author

Immunological Mechanisms and Machine Learning Applications in Post-COVID-19 Syndrome: A Narrative Review.

Microorganisms·2026
Same author

Extreme Eosinophilia and Dyspnea as Presenting Signs of a Metastatic Tumor.

The Israel Medical Association journal : IMAJ·2026
Same author

Artificial Intelligence-Enhanced Cardiac Point-of-Care Ultrasound: A Prospective Single-Arm Study.

Mayo Clinic proceedings. Digital health·2026
Same author

Impact of biologic class and treatment line on psoriatic arthritis risk in psoriasis: a population-based cohort study.

RMD open·2026
Same author

Increased Risk of Incident Uveitis Among Patients with Psoriasis: A Nationwide Population-Based Cohort Study.

Diagnostics (Basel, Switzerland)·2026

Related Experiment Video

Updated: Jan 4, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.2K

Tuftsin-phosphorylcholine attenuate experimental autoimmune encephalomyelitis.

Natalia S Novikova1, Anastasia S Diatlova1, Kristina Z Derevtsova1

  • 1Laboratory of Mosaic of Autoimmunity, Saint Petersburg State University, St. Petersburg, Russian Federation; Department of General Pathology and Pathophysiology, FGBNU "Institute of Experimental Medicine", St. Petersburg, Russian Federation.

Journal of Neuroimmunology
|November 5, 2019
PubMed
Summary

Tuftsin-phosphorylcholine (TPC), a helminth-derived compound, reduced inflammation and demyelination in a mouse model of multiple sclerosis (MS). This suggests TPC may help treat MS by improving clinical outcomes and slowing disease progression.

Keywords:
AutoimmunityExperimental autoimmune encephalomyelitisMultiple sclerosisTuftsin-phosphorylcholine

More Related Videos

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

8.1K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.7K

Related Experiment Videos

Last Updated: Jan 4, 2026

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
05:44

Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice

Published on: October 13, 2023

2.2K
Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo
10:50

Visualizing Impairment of the Endothelial and Glial Barriers of the Neurovascular Unit during Experimental Autoimmune Encephalomyelitis In Vivo

Published on: March 26, 2019

8.1K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.7K

Area of Science:

  • Neuroimmunology
  • Autoimmune diseases

Background:

  • Multiple sclerosis (MS) is a chronic central nervous system (CNS) autoimmune disease with significant morbidity and mortality.
  • Current treatments for MS aim to manage symptoms and slow disease progression, but new therapeutic strategies are needed.

Purpose of the Study:

  • To investigate the therapeutic potential of tuftsin-phosphorylcholine (TPC), a novel immune-modulating compound derived from helminths, in a murine model of MS.

Main Methods:

  • Experimental autoimmune encephalomyelitis (EAE), a mouse model of MS, was induced.
  • Mice with EAE received acute treatment with TPC or a vehicle control.

Main Results:

  • TPC treatment led to improved clinical scores in EAE mice.
  • Significantly reduced CNS inflammation and demyelination were observed in TPC-treated mice compared to controls.

Conclusions:

  • TPC demonstrated a beneficial clinical effect in the EAE model.
  • TPC shows potential for ameliorating clinical manifestations and delaying disease progression in multiple sclerosis.